Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171) [2]

Annals of Oncology

Volumn 16, Issue 7, 2005, Pages 1208-1209

  Contegiacomo, A ^a   Pensabene, M ^a   Capuano, I ^a   Tauchmanova, L ^a   Federico, M ^b   Turchetti, D ^b   Cortesi, L ^b   Marchetti, P ^d   Ricevuto, E ^d   Cianci, G ^d   Barbieri, V ^c   Venuta, S ^c   Silingardi, V ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RISK; EARLY DIAGNOSIS; FAMILIAL CANCER; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; INTERDISCIPLINARY COMMUNICATION; LETTER; MODEL; PEDIGREE ANALYSIS; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; GENETIC SCREENING; GENETICS; HUMAN; NEOPLASM; NOTE; PEDIGREE;

GENETIC COUNSELING; GENETIC SCREENING; HUMANS; NEOPLASMS; PEDIGREE;

EID: 25444489273     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi219     Document Type: Letter

References (6)

1. Mandich P, Cavalli P, Pasini B. Cancer genetic counselling. Ann Oncol 16; 1: 171
2. Contegiacomo A, Pensabene M, Capuano L et al. An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Ann Oncol 2004; 15: 726-732.
3. WHOQOL Group. The development of life assessment instrument (the WHOQOL). In Orley J, Kuyken W (eds): Quality of Life Assessment: International Perspective. Heidelberg: Springer Verlag 1994; 41-57.
4. National Health Plan (NHP) 1998-2000. Available online at http://www.fdgdiabete.it/psn2000/Psnindex.htm (24 January 2005, date last accessed).
5. Nordin K, Lidén A, Hansson M et al. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet 2002; 39: 689-694.
6. Euhus DM, Smith KC, Robinson L et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 2002; 94: 844-851.